Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity

Diabetes Research and Clinical Practice

Volumn 110, Issue 3, 2015, Pages 309-314

  Ajala, Olubukola ^a   Jensen, Louise A ^a   Ryan, Edmond ^a   Chik, Constance ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adiposity; Dyslipidemia; Gestational diabetes; Vascular function

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DYSGLYCEMIA; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HEART OUTPUT; HUMAN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; OBESITY; PREGNANCY DIABETES MELLITUS; PULSE PRESSURE; PULSE RATE; VASCULAR RESISTANCE; WAIST HIP RATIO; ANALYSIS; BLOOD; CASE CONTROL STUDY; DIABETES, GESTATIONAL; DYSLIPIDEMIAS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PUERPERIUM; RISK FACTOR;

ADIPOSITY; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPIDS; OBESITY; POSTPARTUM PERIOD; PREGNANCY; RISK FACTORS; WAIST-HIP RATIO;

EID: 84955207068     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.10.004     Document Type: Article

References (41)

1. DeSisto C.L., Kim S.Y., Sharma A.J. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014, 11:130415.
2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
3. Bellamy L., Casas J., Hingorani A., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
4. Knopp R.H., Chan E., Zhu X., Paramsothy P., Bonet B. Lipids in gestational diabetes: abnormalities and significance. Gestational diabetes during and after pregnancy 2010, 155-169. Springer, New York. C. Kin, A. Ferrara (Eds.).
5. Zimmet P.Z., Alberti K.G.M. The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet 1997, 350:S1-S4.
6. Shah B.R., Retnakaran R., Booth G.L. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008, 31:1668-1669.
7. Poredos P. Endothelial dysfunction in the pathogenesis of atherosclerosis. Int Angiol 2002, 21:109-116.
8. Nigam A., Mitchell G.F., Lambert J., Tardif J. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 2003, 92:395-399.
9. Agabiti-Rosei E., Mancia G., O'Rourke M.F., Roman M.J., Safar M.E., Smulyan H., et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007, 50:154-160.
10. Heffernan K.S., Karas R.H., Patvardhan E.A., Jafri H., Kuvin J.T. Peripheral arterial tonometry for risk stratification in men with coronary artery disease. Clin Cardiol 2010, 33:94-98.
11. DeLoach S.S., Townsend R.R. Vascular stiffness: its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 2008, 3:184-192.
12. Chen C.H., Nevo E., Fetics B., Pak P.H., Yin F.C.P., Maughan W.L., et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997, 95:1827-1836.
13. Wilkinson I.B., Fuchs S.A., Jansen I.M., Spratt J.C., Murray G.D., Cockcroft J.R., et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998, 16:2079-2084.
14. Lobner K., Knopff A., Baumgarten A., Mollenhauer U., Marienfeld S., Garrido-Franco M., et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006, 5:792-797.
15. Emerging Risk Factors Collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320.
16. Retnakaran R., Hanley A.J., Raif N., Connelly P., Sermer M., Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003, 88:3507-3512.
17. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003, 107:499-511.
18. Davenport M.H., Goswami R., Shoemaker J.K., Mottola M.F. Influence of hyperglycemia during and after pregnancy on postpartum vascular function. Am J Physiol Regul Integr Comp Physiol 2012, 302:R768-R775.
19. Anastasiou E., Lekakis J.P., Alevizaki M., Papamichael C.M., Megas J., Souvatzoglou A., et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998, 21:2111-2115.
20. Hannemann M.M., Liddell W.G., Shore A.C., Clark P.M., Tooke J.E. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 2002, 39:311-319.
21. Pleiner J., Mittermayer F., Langenberger H., et al. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes. Wien Klin Wochenschr 2007, 119:483-489.
22. Brewster S., Floras J., Zinman B., Retnakaran R. Endothelial function in women with and without a history of glucose intolerance in pregnancy. J Diabetes Res 2013, 2013:382670.
23. Li J.W., He S.Y., Liu P., Luo L., Zhao L., Xiao Y.B. Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc Disord 2014, 14. 132-2261-14-132.
24. Canadian Diabetes Association 2008 clinical practice guidelines diabetes and pregnancy. Can J Diabetes 2008, 32:S168-S180.
25. Ciccone M.M., Scicchitano P., Cameli M., Cecere A., Cortese F., Dentamaro I., et al. Endothelial function in pre-diabetes diabetes and diabetic cardiomyopathy: a review. J Diabetes Metab 2014, 5:364.
26. Pannacciulli N., De Pergola G., Ciccone M., Rizzon P., Giorgino F., Giorgino R. Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care 2003, 26(4):1230-1234.
27. Ciccone M.M., Bilianou E., Balbarini A., Gesualdo M., Ghiadoni L., Metra M., et al. Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med (Hagerstown) 2013, 14(10):757-766.
28. Verma A., Boney C., Tucker R., Vohr B. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002, 87:3227-3235.
29. Kousta E., Lawrence N.J., Godsland I.F., Penny A., Anyaoku V., Millauer B.A., et al. Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol 2003, 59:289-297.
30. Di C., Lencioni C., Volpe L., Ghio A., Cuccuru I., Pellegrini G. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007, 23:135-140.
31. Ridker P., Hennekens C., Buring J., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
32. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study. Diabetes 2002, 51:1596-1600.
33. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R., Haffner S. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000, 102:42-4733.
34. Ku Y.H., Choi S.H., Lim S., Cho Y.M., Park Y.J., Park K.S., et al. Carotid intimal-medial thickness is not increased in women with previous gestational diabetes mellitus. Diabetes Metab J 2011, 35:497-503.
35. Retnakaran R., Hanley A., Raif N., Connelly P., Sermer M., Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003, 88:3507-3512.
36. Wolf M., Sandler L., Hsu K., Vossen-Smirnakis K., Ecker J., Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003, 26:819-824.
37. McLachlan K., O'Neal D., Jenkins A., Alford F. Do adiponectin TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes/Metab Res Rev 2006, 22(2).
38. Bo S., Valpreda S., Menato G., Bardelli C., Botto C., Gambino R., et al. Should we consider gestational diabetes a vascular risk factor?. Atherosclerosis 2007, 194(2):e72-e79.
39. Volpe L., Cuccuru I., Lencioni C., Napoli V., Ghio A., Fotino C., et al. Early subclinical atherosclerosis in women with previous gestational diabetes mellitus. Diabetes Care 2008, 31(5):e32-e0047.
40. Akinci B., Celtik A., Genc S., Yener S., Demir T., Secil M., et al. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes. Gynecol Endocrinol 2011, 27(5):361-367.
41. Fakhrzadeh H., Alatab S., Sharifi F., Mirarefein M., Badamchizadeh Z., Ghaderpanahi M., et al. Carotid intima media thickness, brachial flow mediated dilation and previous history of gestational diabetes mellitus. J Obstet Gynaecol Res 2012, 38(8):1057-1063.